Table 4. Synopsis of maximum lysis and EC50 values for patient samples.

	Maximum Specific Lysis [%]				EC50 [pM] (95% CI [pM])
	19-3	19-3-19	MabThera®	19-3	19-3-19	MabThera®
Patient 1	79.3	70.8	n.d.	1.2 (0.3 - 5)	48.1 (9 - 270)	n.d.
Patient 2	61.5	59.2	72.8	6.1 (4 - 10)	4.8 (3 - 9)	185.7 (135 - 255)
Patient 3	98	100	44.5	2.8 (1 - 8)	6.4 (4 - 11)	1,300 (426 – 4,224)
Patient 4	49.4	44.7	8.4	10.7 (1 - 177)	13.9 (2 - 84)	9,900 (0.1 - 568 nM)
Patient 5	51.3	48.8	43.9	6.7 (1 - 36)	7.1 (2 - 29)	247.5 (89 - 688)